Joseph A. Leveque

1.0k total citations
30 papers, 547 citations indexed

About

Joseph A. Leveque is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Joseph A. Leveque has authored 30 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Joseph A. Leveque's work include Cancer Immunotherapy and Biomarkers (5 papers), Acute Myeloid Leukemia Research (4 papers) and Platelet Disorders and Treatments (3 papers). Joseph A. Leveque is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Acute Myeloid Leukemia Research (4 papers) and Platelet Disorders and Treatments (3 papers). Joseph A. Leveque collaborates with scholars based in United States, France and Australia. Joseph A. Leveque's co-authors include Roger M. Lyons, Hagop M. Kantarjian, Mikkael A. Sekeres, Alan F. List, Francis J. Giles, Sherry Pierce, Robert Deuson, R London, T. G. Wilson and Katherine D. LaGuardia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Joseph A. Leveque

28 papers receiving 509 citations

Peers

Joseph A. Leveque
Michelle A. Roesler United States
G Kardos Hungary
David P. Sheridan Canada
Benjamin Barnes Germany
Dragana Janić Serbia
Eveline de Bont Netherlands
C. Lindemalm Sweden
A Bröcker-Vriends Netherlands
Sze Chai Chan Hong Kong
José Villagra United States
Michelle A. Roesler United States
Joseph A. Leveque
Citations per year, relative to Joseph A. Leveque Joseph A. Leveque (= 1×) peers Michelle A. Roesler

Countries citing papers authored by Joseph A. Leveque

Since Specialization
Citations

This map shows the geographic impact of Joseph A. Leveque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Leveque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Leveque more than expected).

Fields of papers citing papers by Joseph A. Leveque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph A. Leveque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Leveque. The network helps show where Joseph A. Leveque may publish in the future.

Co-authorship network of co-authors of Joseph A. Leveque

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Leveque. A scholar is included among the top collaborators of Joseph A. Leveque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Leveque. Joseph A. Leveque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Garon, Edward B., David T. Wong, Jeffrey Schneider, et al.. (2018). MA04.02 Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-PD-1. Journal of Thoracic Oncology. 13(10). S366–S367. 1 indexed citations
3.
Autio, Karen A., Aung Naing, Annie Hung, et al.. (2018). Durability of clinical benefit in metastatic epithelial ovarian cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. Annals of Oncology. 29. viii408–viii408. 2 indexed citations
4.
Jakubowiak, Andrzej, Dominik Dytfeld, Sundar Jagannath, et al.. (2011). Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM). Blood. 118(21). 631–631. 18 indexed citations
5.
Godey, Florence, Claude Bendavid, Patrick Tas, et al.. (2011). P238 Breast sentinel lymph node analysis intraoperative with OSNA (One step Nucleic Acid Amplification) to avoid second surgery for axillary lymph node dissection. The Breast. 20. S56–S57. 1 indexed citations
6.
Morcel, Karine, et al.. (2008). Pyoderma gangrenosum et cancer du sein : à propos d’un cas. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 37(6). 618–621. 10 indexed citations
7.
Kantarjian, Hagop M., Francis J. Giles, Alan F. List, et al.. (2007). The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer. 109(9). 1705–1714. 176 indexed citations
8.
Kantarjian, Hagop M., et al.. (2007). P127 Prospective cross-sectional analysis of cytopenias and transfusion needs of MDS patients in the USA. Leukemia Research. 31. S108–S109. 1 indexed citations
9.
Kantarjian, Hagop M., Francis J. Giles, Alan F. List, et al.. (2007). The incidence and impact of thrombocytopenia in myelodysplastic syndrome. 5. 74–75. 1 indexed citations
10.
Aledort, Louis M., Roger M. Lyons, Gary J. Okano, & Joseph A. Leveque. (2006). The Clinical and Direct Medical Cost Burden of Splenectomy among Managed Care Patients with Chronic Immune Thrombocytopenic Purpura (ITP).. Blood. 108(11). 5536–5536. 4 indexed citations
11.
Aledort, Louis M., Roger M. Lyons, Gary J. Okano, & Joseph A. Leveque. (2006). Retrospective Matched Cohort Study of Immune Thrombocytopenic Purpura (ITP): Complications Related to Corticosteroid (CS) Use.. Blood. 108(11). 3295–3295. 12 indexed citations
12.
Gernsheimer, Terry, et al.. (2006). Standard of Care in Patients with Immune Thrombocytopenic Purpura: A Retrospective Chart Analysis.. Blood. 108(11). 3990–3990. 1 indexed citations
13.
Guitton, Nathalie, et al.. (2003). Alkaline single-cell gel electrophoresis (comet assay). European Journal of Cancer. 40(3). 445–451. 47 indexed citations
14.
Guitton, Nathalie, et al.. (2001). Genomic instability and breast cancer. Oncology Reports. 8(5). 1001–5. 21 indexed citations
15.
Rioux‐Leclercq, Nathalie, et al.. (2000). Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.. PubMed. 11(2). 217–24. 11 indexed citations
16.
Trussell, James, Joseph A. Leveque, J Koenig, et al.. (1995). The economic value of contraception: a comparison of 15 methods.. American Journal of Public Health. 85(4). 494–503. 184 indexed citations
17.
Swanson, Gregory P. & Joseph A. Leveque. (1990). Nephrotic syndrome associated with ant bite.. PubMed. 86(3). 39–41. 9 indexed citations
18.
Leveque, Joseph A., et al.. (1983). Effect of ethanol on the immune system in mice. Toxicology Letters. 19(1-2). 147–153. 7 indexed citations
19.
Leveque, Joseph A., et al.. (1965). [Study of the histaminopexic ability of human serum in 485 subjects].. PubMed. 10(8). 833–8.
20.
Leveque, Joseph A., et al.. (1960). [Hemineurine in oral form in the therapy of the acute complications of alcoholism].. PubMed. 137. 590–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle A. Roesler Breakdown of academic impact, for papers by G Kardos Breakdown of academic impact, for papers by David P. Sheridan Breakdown of academic impact, for papers by Benjamin Barnes Breakdown of academic impact, for papers by Dragana Janić Breakdown of academic impact, for papers by Eveline de Bont Breakdown of academic impact, for papers by C. Lindemalm Breakdown of academic impact, for papers by A Bröcker-Vriends Breakdown of academic impact, for papers by Sze Chai Chan Breakdown of academic impact, for papers by José Villagra
Rankless by CCL
2026